Alberta funds anti-nausea and vomiting chemotherapy drug
This article was originally published in Scrip
Executive Summary
Cancer patients in Alberta, Canada, now have the funded option of Emend (aprepitant), Merck Frosst’s (Merck and Co) oral medicine for the prevention of nausea and vomiting triggered by some types of chemotherapy.